Mottiwala Aziz 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Mottiwala Aziz
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-06-08$20.00/sh−100$2,000→ 48,086 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022.